LCLAT1 and brain neoplasm: Sox2 is highly expressed in many pediatric brain tumors, including ETMR,55 and its downregulation here, either directly by p21 or through other mechanisms, further supports the anti-oncogenic impact of CL remodeling by LCLAT1.